facility and its 5550 Lakeview Parkway operations.
New associates will be hired at both Beckman Coulter’s 5355 W. “This company’s trend of growth continues to create life sciences and manufacturing opportunities for Hoosiers.”īeckman Coulter, which has been in Indianapolis since acquiring a locally based high-tech start-up in December of 1996, plans to begin hiring additional employees immediately. “Once again, Beckman Coulter is recognizing that Indiana is a cost-effective environment to further grow its business,” said Governor Mitch Daniels. The company, which develops, manufactures and markets testing instruments and supplies for hospital laboratories as well as scientific research and drug discovery, will invest more than $18.2 million to add new equipment at its 5355 W. Since 2007, the company has grown by over 350 percent, adding 390 new jobs in Indianapolis. “Cytobank looks forward to joining Beckman Coulter Life Sciences, and leveraging synergies to help us further develop and support our platform to serve leading scientists globally,” said David Craford, President & CEO, Cytobank.Ĭytobank will transition into Beckman Coulter Life Sciences under the Danaher Life Sciences platform, which generated approximately $6.5 billion in revenue during 2018.OctoBeckman Coulter Expands Biomedical Ops - Business Facilities Magazineīeckman Coulter, a manufacturer of biomedical test instruments and supplies has announced it will expand its operations for the third time in the last four years, creating up to 95 new jobs by 2013. “We can now provide more standardized, yet flexible high-end data analytics solutions to Pharma/Biopharma and leading Academic clinical research customers.”
“We are excited to add Cytobank’s innovative software solutions and customer workflow-focused team to our flow cytometry business,” said Mario Koksch, Flow Cytometry Business Unit Vice President and General Manager, Beckman Coulter Life Sciences. The technology pairs naturally with Beckman Coulter Life Sciences’ CytoFLEX LX 21-color flow cytometer to meet the growing high-complexity workflow and data analysis needs of basic and clinical research scientists. The platform accelerates research productivity by enabling efficient high-dimensional multi-omics data analysis, visualization and collaboration across multiple sites. (INDIANAPOLIS, INDIANA – June 4, 2019) – Beckman Coulter Life Sciences today announced its acquisition of Cytobank, a privately held, single cell data analysis, software as a service (SaaS) company based in Santa Clara, California.Ĭytobank provides an industry-leading, cloud and machine learning-based software platform for multi-parametric single-cell data analysis, sharing and archiving.
CytoFLEX Violet-Blue-Red Series Upgrades.Labware for Liquid Handling Instruments.Lysing, Fixative, and Permeabilizating Reagents.RESOURCE Contract Manufacturing Services.